6.695
price up icon1.06%   0.07
after-market After Hours: 6.56 -0.135 -2.02%
loading
Scisparc Ltd stock is traded at $6.695, with a volume of 3,226. It is up +1.06% in the last 24 hours and up +40.95% over the past month. SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two operating reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.
See More
Previous Close:
$6.625
Open:
$6.5
24h Volume:
3,226
Relative Volume:
0.00
Market Cap:
$3.84M
Revenue:
$856.00K
Net Income/Loss:
$-12.56M
P/E Ratio:
-0.0289
EPS:
-231.4926
Net Cash Flow:
$-4.14M
1W Performance:
+1.59%
1M Performance:
+40.95%
6M Performance:
+42.21%
1Y Performance:
-82.41%
1-Day Range:
Value
$6.50
$6.81
1-Week Range:
Value
$6.22
$7.60
52-Week Range:
Value
$2.98
$80.10

Scisparc Ltd Stock (SPRC) Company Profile

Name
Name
Scisparc Ltd
Name
Phone
-
Name
Address
-
Name
Employee
3
Name
Twitter
Name
Next Earnings Date
2026-07-29
Name
Latest SEC Filings
Name
SPRC's Discussions on Twitter

Compare SPRC vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SPRC icon
SPRC
Scisparc Ltd
6.695 3.80M 856.00K -12.56M -4.14M -231.49
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
548.05 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
834.04 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,039.78 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
145.13 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
209.46 45.38B 742.00K -1.37B -1.07B -7.0731

Scisparc Ltd Stock (SPRC) Latest News

pulisher
Aug 20, 2026

SciSparc Ltd.Ordinary Shares (NQ: SPRC - The Chronicle-Journal

Aug 20, 2026
pulisher
Aug 19, 2026

SciSparc | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment) - Moomoo

Aug 19, 2026
pulisher
Aug 19, 2026

Scisparc posts audited 2025 net loss of USD 12.56 million - Bitget

Aug 19, 2026
pulisher
Aug 19, 2026

SciSparc : Amendment to Annual Report by Foreign Issuer (Form 20-F/A) - marketscreener.com

Aug 19, 2026
pulisher
Aug 18, 2026

SciSparc Boosts NeuroThera Stake in C$5.4 Million Financing - TipRanks

Aug 18, 2026
pulisher
Aug 18, 2026

SciSparc (NASDAQ: SPRC) backs NeuroThera in C$5.4M raise - Stock Titan

Aug 18, 2026
pulisher
Aug 18, 2026

SciSparc funds NeuroThera Labs spinoff with CAD 5.4m financing round - AllSci

Aug 18, 2026
pulisher
Aug 18, 2026

SciSparc invests C$2.7M in subsidiary NeuroThera financing By Investing.com - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

SciSparc Invests C$2.7 Million in NeuroThera Financing, Increases Stake to Approximately 44.6% - Moomoo

Aug 18, 2026
pulisher
Aug 18, 2026

SciSparc: Subsidiary NeuroThera Labs Completes C$5.4 - GlobeNewswire

Aug 18, 2026
pulisher
Aug 17, 2026

Neurothera Labs Inc. Closes Final Tranche of Non-Brokered Private Placement - TheNewswire

Aug 17, 2026
pulisher
Aug 17, 2026

SciSparc (SPRC) Gains 1.59% as Shares Hold Firm Above $6 Support ZonePut Call Ratio - vinanet.vn

Aug 17, 2026
pulisher
Aug 13, 2026

SciSparc Ltd. (SPRC) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 13, 2026
pulisher
Aug 12, 2026

NeuroThera Labs Inc. Closes First Tranche of Non-Brokered Private Placement - NewMediaWire

Aug 12, 2026
pulisher
Aug 12, 2026

NeuroThera Labs Inc. Closes First Tranche Of Non-Brokered Private Placement - TheNewswire

Aug 12, 2026
pulisher
Aug 12, 2026

SciSparc Ltd. (SPRC) stock price, news, quote and history - Yahoo Finance UK

Aug 12, 2026
pulisher
Aug 12, 2026

SciSparc Subsidiary NeuroThera Wins Japanese Patent for Novel Pain and Fever Therapy - TipRanks

Aug 12, 2026
pulisher
Aug 12, 2026

SciSparc Ltd. (Nasdaq: SPRC) subsidiary gains Japanese patent on novel pain treatment combo - Stock Titan

Aug 12, 2026
pulisher
Aug 12, 2026

SciSparc’s Subsidiary NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination - The Manila Times

Aug 12, 2026
pulisher
Aug 12, 2026

SciSparc Subsidiary NeuroThera Receives Japanese Patent for 4-Aminophenol Combination Therapy - Quiver Quantitative

Aug 12, 2026
pulisher
Aug 12, 2026

Japanese patent covers SciSparc subsidiary’s pain and fever combo - Stock Titan

Aug 12, 2026
pulisher
Aug 12, 2026

NeuroThera Labs Granted Japanese Patent for its Proprietary, Innovative Therapeutic Combination - TradingView

Aug 12, 2026
pulisher
Aug 10, 2026

SPRC Stock Price, Quote & Chart - ChartMill

Aug 10, 2026
pulisher
Aug 10, 2026

SciSparc (SPRC) Slips 0.87% to $6.87 as Biotech Stock Holds Above Key SupportTrend Continuation Trade - dars.gov.et

Aug 10, 2026
pulisher
Aug 07, 2026

Scisparc Ltd (SPRC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

Scisparc Ltd (SPRC) Stock News Today - TradingKey

Aug 07, 2026
pulisher
Aug 06, 2026

SciSparc’s NeuroThera Launches Phase IIb Tourette Trial at Yale Child Study Center - TipRanks

Aug 06, 2026
pulisher
Aug 05, 2026

SciSparc (Nasdaq: SPRC) launches Phase IIb SCI-110 Tourette study - Stock Titan

Aug 05, 2026
pulisher
Aug 05, 2026

SciSparc’s NeuroThera Opens Yale Site for Phase IIb SCI-110 Tourette Syndrome Trial - Quiver Quantitative

Aug 05, 2026
pulisher
Aug 05, 2026

Tourette drug candidate enters Phase IIb with prior 21% tic reduction - Stock Titan

Aug 05, 2026
pulisher
Aug 04, 2026

Price to book forward of SciSparc Ltd. – NASDAQ:SPRC - TradingView

Aug 04, 2026
pulisher
Aug 04, 2026

SciSparc (SPRC) Slips Slightly as Shares Test Key Support Near $7.11Weak Sell Signals - vinanet.vn

Aug 04, 2026
pulisher
Aug 02, 2026

SciSparc (SPRC) Plunges 18.16% — Support at $6.76 Becomes CriticalRegression Channel - Vinanet

Aug 02, 2026
pulisher
Jul 31, 2026

SciSparc Announces NeuroThera Labs Achieves Milestone in Quantum-Enabled Clinical Trial Data Analytics Platform - Quiver Quantitative

Jul 31, 2026
pulisher
Jul 31, 2026

Quantum clinical analytics milestone at SciSparc (Nasdaq: SPRC) - Stock Titan

Jul 31, 2026
pulisher
Jul 30, 2026

SciSparc (SPRC) Drops 4.29% as Shares Test Key Support Near $8.26Retail Sentiment - dars.gov.et

Jul 30, 2026
pulisher
Jul 30, 2026

Enterprise value to EBIT forward of SciSparc Ltd. – NASDAQ:SPRC - TradingView

Jul 30, 2026
pulisher
Jul 29, 2026

SciSparc (SPRC) Surges Over 70%: Analyzing the Massive RallyHigh Volume Stocks - dars.gov.et

Jul 29, 2026
pulisher
Jul 29, 2026

SciSparc Moves Into Agentic AI With New Scientific Advisory Board - TipRanks

Jul 29, 2026
pulisher
Jul 29, 2026

Scisparc Ltd. Announces Establishment of Scientific Advisory Board - marketscreener.com

Jul 29, 2026
pulisher
Jul 29, 2026

SciSparc: Subsidiary NeuroThera Labs Advances its Quantum - GlobeNewswire

Jul 29, 2026
pulisher
Jul 29, 2026

SciSparc (Nasdaq: SPRC) targets agentic AI, advances quantum platform - Stock Titan

Jul 29, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Earnings Date & Reports & Earnings News - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

SciSparc shifts focus to agentic AI market - Investing.com

Jul 27, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Scisparc Ltd (SPRC) Institutional Confidence - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

SciSparc shifts focus to agentic AI market By Investing.com - Investing.com Canada

Jul 27, 2026
pulisher
Jul 27, 2026

SciSparc Announces Decision to Target the Agentic AI Market; Forms Scientific Advisory Board for Artificial Intelligence and Cybersecurity - The Manila Times

Jul 27, 2026

Scisparc Ltd Stock (SPRC) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$61.31
price up icon 1.21%
$125.77
price up icon 0.55%
$116.57
price up icon 5.12%
$236.22
price up icon 3.02%
ONC ONC
$374.47
price up icon 1.44%
$209.46
price down icon 1.07%
Cap:     |  Volume (24h):